Fritextsökning
Innehållstyper
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Topp 10 mest sålda läkemedel
Top tio-listan av de läkemedel som sålt bäst på den amerikanska marknaden
-
Density meters with six-digit precision
The new instruments from Krüss Optronic offer high sensitivity for density measurements.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Sekvenseringsjätten BGI satsar på molnet
Analys och datalagring av DNA-sekvenser tar stora datorresurser i anspråk.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Torgny Fornstedt: Analytisk kemi måste hitta tillbaka till sina rötter
Det behövs fler kunniga analytiska kemister både på universiteten och inom industrin, skriver Torgny Fornstedt i en krönika.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Anrikning av DNA med fokus på cancerforskning
Med nya kit kan man anrika DNA-prover för effektivare studier av en rad viktiga cancerrelaterade gener.
-
Pfizer kan ta upp jakten
Om Astrazeneca är villigt kan nya samtal om uppköp inledas redan nästa vecka.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young...
-
Astrazeneca hotas med stämning
Anklagas för kartellverksamhet. Ska tillsammans med tre generikabolag ha påverkat kopior av magsårsläkemedlet Nexium.
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...
-
Automatisk av- och påskruvning av provrörslock
Ett system för halvautomatisk avskruvning och påskruvning av lock på provrör.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Valeant lägger bud på Allergan
Budfesten fortsätter. Nu vill Valeant köpa upp botox-tillverkaren Allergan.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Hon skrev bästa avhandlingen
”En doktorsavhandling av hög kvalitet som uppvisar en utmärkt förmåga att kommunicera vetenskap och resultat.” Så löd motiveringen när Rosenön Award delades ut.
BREAKING